Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

Using STS/ACC registry data, the authors updated 30-day outcomes and present 1 year outcomes for TAVR pts.  Over 12,000 pts were in the registry; median age was 84, and STS predicted operative mortality risk was 7.1%.   30-day mortality was 7.0%, 1-year mortality was 23.7%.  1-year mortality was associated with advanced age, male sex, end-stage renal disease, COPD, non-transfemoral access, high predicted risk, and preoperative afib.